These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3182623)

  • 1. Plasma neurochemistry in juvenile offenders.
    Pliszka SR; Rogeness GA; Renner P; Sherman J; Broussard T
    J Am Acad Child Adolesc Psychiatry; 1988 Sep; 27(5):588-94. PubMed ID: 3182623
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder.
    Bowden CL; Deutsch CK; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1988 Mar; 27(2):171-4. PubMed ID: 3360718
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activities in psychotic patients.
    Zizolfi S; Famiglietti LA; Del Vecchio M; Kemali D
    Acta Neurol (Napoli); 1979 Apr; 1(2):142-9. PubMed ID: 474224
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical differences in children with conduct disorder socialized and undersocialized.
    Rogeness GA; Hernandez JM; Macedo CA; Mitchell EL
    Am J Psychiatry; 1982 Mar; 139(3):307-11. PubMed ID: 7058944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet MAO-B, personality, and psychopathology.
    Ruchkin VV; Koposov RA; af Klinteberg B; Oreland L; Grigorenko EL
    J Abnorm Psychol; 2005 Aug; 114(3):477-82. PubMed ID: 16117585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
    Xavier Vieira R; Azevedo M; Polónio P; Manso C
    Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relation among plasma dopamine beta-hydroxylase, monoamine oxidase and Cu++].
    Stagni S; Mello P; Gualandi S; Guidi M; Illuminati B; Scanabissi E
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1603-6. PubMed ID: 7459081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between platelet and plasma monoamine oxidase, plasma dopamine-beta-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol.
    Belmaker R; Beckmann H; Goodwin F; Murphy D; Pollin W; Buchsbaum M; Wyatt R; Ciaranello P; Lamrecht F
    Life Sci; 1975 Jan; 16(2):273-80. PubMed ID: 1110604
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia.
    Jeste DV; Phelps B; Wagner RL; Wise CD; Wyatt RJ
    Lancet; 1979 Oct; 2(8147):850-1. PubMed ID: 90943
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet monoamine oxidase, plasma dopamine-beta-hydroxylase and attention in a "biochemical high risk" sample.
    Buchsbaum MS; Murphy DL; Coursey RD; Lake CR; Zeigler MG
    J Psychiatr Res; 1978; 14(1-4):215-24. PubMed ID: 722628
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet monoamine oxidase in children with infantile autism.
    Boullin DJ; Bhagavan HN; Coleman M; O'Brien RA; Youdim MB
    Med Biol; 1975 Aug; 53(4):210-3. PubMed ID: 1186319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities.
    Murphy DL; Wyatt RJ
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():277-88. PubMed ID: 769115
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
    Wagner RL; Jeste DV; Phelps BH; Wyatt RD
    J Clin Psychopharmacol; 1982 Oct; 2(5):312-4. PubMed ID: 7130432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biochemical study of tardive dyskinesia in young male patients.
    Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ
    Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum DBH and platelet MAO in patients with depressive disorders.
    Honecker H; Fähndrich E; Coper H; Helmchen H
    Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of exercise on human blood platelet serotonin uptake and monoamine oxidase activity.
    Jensen PN; Møller HJ; Smith DF; Rosenberg R
    Biol Psychiatry; 1995 Jul; 38(2):125-7. PubMed ID: 7578646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.